Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bipolar I Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00114686
What this trial is testing

Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Alcohol Dependency in Patients With Bipolar Disorder

Who this might be right for
Bipolar I DisorderAlcohol Dependence
AstraZeneca 350
Not applicableWithdrawnNCT00726154
What this trial is testing

Pilot Study of the Effects of Circadian Rhythms on the Treatment of Bipolar I Depression.

Who this might be right for
Bipolar Disorder
University of Pittsburgh
Early research (Phase 1)Study completedNCT07549581
What this trial is testing

SEP-380135 in Adults With Schizophrenia or Major Depressive Episode

Who this might be right for
SchizophreniaMajor Depressive Disorder (MDD)Bipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 43
Large-scale testing (Phase 3)Ended earlyNCT05169710
What this trial is testing

A Clinical Study of an Investigational Drug for the Treatment of Major Depressive Episode Associated With Bipolar I Disorder.

Who this might be right for
Depressive Episodes, Bipolar I Depression
Sumitomo Pharma America, Inc. 83
Large-scale testing (Phase 3)Study completedNCT04819776
What this trial is testing

Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder

Who this might be right for
Bipolar I Disorder
Vanda Pharmaceuticals 417
Large-scale testing (Phase 3)Ended earlyNCT01121536
What this trial is testing

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Who this might be right for
Depression
Cephalon 867
Not applicableStudy completedNCT00595387
What this trial is testing

Effectiveness of Cognitive Behavioral Therapy for Treating Depression in People With Bipolar I Disorder

Who this might be right for
Bipolar DisorderDepression
Massachusetts General Hospital 54
Not applicableStudy completedNCT01202604
What this trial is testing

A Study Evaluating the Efficacy of Administered Maintenance Treatments in Bipolar Disorder I and II.

Who this might be right for
Bipolar Disorder
AstraZeneca 294
Testing effectiveness (Phase 2)Study completedNCT04030143
What this trial is testing

A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 Disorder

Who this might be right for
SchizophreniaBipolar I Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 266
Not applicableLooking for participantsNCT07622927
What this trial is testing

FOCUS Bipolar: Families Opening Conversations for Understanding Signs

Who this might be right for
Bipolar Disorder (BD)Bipolar Disorder I or IIBipolar Disorder Family Members+1 more
University of Texas Southwestern Medical Center 200
Large-scale testing (Phase 3)Study completedNCT02046369
What this trial is testing

Lurasidone Pediatric Bipolar Study

Who this might be right for
Bipolar I Depression
Sumitomo Pharma America, Inc. 350
Testing effectiveness (Phase 2)Looking for participantsNCT07185815
What this trial is testing

Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine

Who this might be right for
SchizophreniaBipolar I DisorderMajor Depressive Disorder
Mapi Pharma Ltd. 24
Not applicableTemporarily pausedNCT06129500
What this trial is testing

CBT for Problematic Impulsive Behaviours in Bipolar Disorder: A Case Series / CBT-PIB

Who this might be right for
ImpulsivityBipolar DisorderHypomania+4 more
University of Exeter 10
Large-scale testing (Phase 3)Study completedNCT00036348
What this trial is testing

Study of Aripiprazole in Patients With a History of Bipolar Disorder

Who this might be right for
Bipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc.
Testing effectiveness (Phase 2)Study completedNCT05004896
What this trial is testing

Ketamine for Treatment-Resistant Bipolar Disorder

Who this might be right for
Bipolar DisorderBipolar DepressionBipolar I Disorder+1 more
Joshua Rosenblat 71
Very early researchStudy completedNCT02593643
What this trial is testing

Effect of Ketamine vs. Active Placebo on Suicidal Ideation in Depressed Inpatients With Major Depressive Disorder or Bipolar Depression.

Who this might be right for
Major Depressive DisorderBipolar I DisorderBipolar II Disorder+2 more
Sunnybrook Health Sciences Centre 9
Large-scale testing (Phase 3)Active Not RecruitingNCT06608641
What this trial is testing

Efficacy and Safety of Endoxifen in Bipolar I Disorder Patients

Who this might be right for
Bipolar 1 Disorder
Jina Pharmaceuticals Inc. 490
Early research (Phase 1)Study completedNCT03624322
What this trial is testing

Safety and Tolerability of INP105 (Olanzapine by I231 POD® Device) Nasal Spray in Healthy Volunteers - SNAP 101

Who this might be right for
Acute Agitation
Impel Pharmaceuticals 38
Large-scale testing (Phase 3)Looking for participantsNCT06951711
What this trial is testing

Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)

Who this might be right for
Bipolar Disorder Type I With Mania or Mania With Mixed Features
Bristol-Myers Squibb 274
Large-scale testing (Phase 3)Study completedNCT00132678
What this trial is testing

The Safety and Efficacy of Injectable Risperidone in the Prevention of Bipolar Mood Episodes

Who this might be right for
Bipolar Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 559
Next Page